Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.
India’s AI education ambitions are colliding with the stark reality of missing digital infrastructure, undertrained teachers ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果